Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 2018 Jun 5;84(8):1857. doi: 10.1111/bcp.13633

Reply to Iuga and Genaidy ‘Comment on Falconer et al. (2018) – the need for specific adverse drug reaction outcomes‘

Nazanin Falconer 1,✉, Michael Barras 1,2, Neil Cottrell 1
PMCID: PMC6046482  PMID: 29873096

We thank Iuga and Genaidy 1 for their letter regarding our systematic review of predictive risk models for adverse drug events in hospitalized patients 2. We agree that models for specific adverse drug events (ADEs), such as the HAS‐BLED score to quantify bleeding risk 3 and the HA‐AKI score to predict acute kidney injury 4, are extremely valuable in clinical practice, particularly to develop actionable interventions. However, the aim of our systematic review was to identify studies where risk scores were developed to predict the imminent risk of any in hospital ADEs (not specific ones) and ADEs only (not harm from any other causes e.g. kidney injury due to dehydration). We also acknowledge that explicit adverse drug outcomes may improve model performance, but so may other factors, and this was not an aim of the study. We do intend to prospectively evaluate two models from our review in a local patient population.

Competing Interests

There are no competing interests to declare.

Falconer, N. , Barras, M. , and Cottrell, N. (2018) Reply to Iuga and Genaidy ‘Comment on Falconer et al. (2018) – the need for specific adverse drug reaction outcomes‘. Br J Clin Pharmacol, 84: 1857 10.1111/bcp.13633.

References

  • 1. Iuga A, Genaidy A. Comment on Falconer et al. (2018) – the need for specific adverse drug reaction outcomes. Br J Clin Pharmacol 2018; 84: 1856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Falconer N, Barras M, Cottrell N. Systematic review of predictive risk models for adverse drug events in hospitalized patients. Br J Clin Pharmacol 2018; 84: 846–864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user‐friendly score (HAS‐BLED) to assess 1‐year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. Chest 2010; 138: 1093–1100. [DOI] [PubMed] [Google Scholar]
  • 4. Hodgson LE, Dimitrov BD, Roderick PJ, Venn R, Forni LG. Predicting AKI in emergency admissions: an external validation study of the acute kidney injury prediction score (APS). BMJ Open 2017; 7: e013511. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES